Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
References Alhiary, R., Kesselheim, A
Umbrella Labs Announces Forthcoming Retatrutide Endocrine Dynamics Research Program To Advance Mechanistic Non-Clinical Science TUCSON, AZ / ACCESS Newswire / November 27, 2025 / Umbrella Labs today announced the development of a multi-phase, non-clinical research program centered on Retatrutide (LY-3437943), designed to characterize peptide behavior, assay performance, and endocrine-signaling dynamics in laboratory models with a level of rigor typically reserved for peer-reviewed translational work
Reach out to us for detailed information, usage guidance, or any other queries
For a quick refresher on dosage amounts, visit a helpful video tutorial or consult your healthcare provider
US$ 21.23
US$ 21.12
US$ 23.24
US$ 26.89
